The CHRND gene helps make part of the muscle receptor that receives signals from nerves and tells a muscle to contract. If this gene does not work properly, those signals may not pass along well, which can lead to muscle weakness, easy tiring, droopy eyelids, or breathing and feeding problems, often starting in infancy. Some people with more disruptive variants have reduced movement before birth and may be born with stiff joints. This gene is mainly known in medical genetics rather than popular culture.
What is a gene?
A gene is a section of DNA that carries information your cells use to make molecules or regulate processes in the body. Some genes hold the information needed to make proteins, the working parts of cells. Other genes mainly help regulate when specific processes happen, where they happen, and how strongly they occur. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, you can read more in the LearnHub.
Overview
CHRNDGene function
What if the gene works
The CHRND gene helps build a receptor on muscle cells that receives nerve signals. Where nerves meet muscles, this receptor responds to acetylcholine and helps start normal muscle contraction.
Risk
What if the gene does not work
Variants in the CHRND gene can impair nerve to muscle signaling, causing congenital myasthenic syndrome with weakness and easy tiring. More severe variants may reduce fetal movement and cause joint contractures, with effects ranging from milder to life limiting.
Treatment
What does that mean for your treatment
For pathogenic loss-of-function variants in the CHRND gene, treatment often uses medicines that strengthen nerve-to-muscle signaling, especially pyridostigmine. Some people also benefit from 3,4-diaminopyridine or albuterol (salbutamol), while drug choice can differ if a CHRND variant causes slow-channel disease rather than receptor deficiency.
Conditions associated with CHRND
Gene function
What if the gene works
Everyday movement depends on clear communication between nerves and muscles. The CHRND gene helps build a receiver on muscle cells at the neuromuscular junction, where a nerve passes along the signal to contract. When this gene is working properly, muscle cells can recognize that message and turn it into smooth, controlled movement.
On muscle cells, the CHRND gene helps form a receptor that catches acetylcholine, the chemical message released by motor nerves. This is a key step in how nerves signal muscles to move.
When acetylcholine binds, this receptor changes shape and opens a tiny channel in the muscle cell membrane. Charged particles then move in, starting the electrical signal that prepares the muscle fiber to contract.
The CHRND gene provides one of the building parts of the muscle acetylcholine receptor. Its protein fits with the other subunits so the receptor can sit in the neuromuscular junction and work as a coordinated unit.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and help create normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. In some situations, though, a variant changes how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CHRND gene can alter the delta part of the acetylcholine receptor, so the receptor is made poorly, folds incorrectly, reaches the muscle cell surface in lower amounts, or opens and closes abnormally. This is how variants in the CHRND gene affect neuromuscular signaling in congenital myasthenic syndrome. Milder variants may leave some receptor activity, while more severe variants can greatly reduce it and are often linked to earlier symptoms or more marked weakness.
How variants are linked to conditions
The main conditions linked to CHRND gene variants are congenital myasthenic syndrome and multiple pterygium syndrome, including Escobar syndrome and more severe fetal forms. In these inherited conditions, pathogenic variants in the CHRND gene can confirm the diagnosis rather than simply indicate a higher chance of disease. Some people mainly have muscle weakness that often starts early in life, while others have reduced fetal movement, joint contractures, and related skeletal changes.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely seen in the general population. Most have no direct impact on health and simply reflect natural human variation. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors contribute. In some situations, though, one well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For CHRND, there is not much broadly confirmed evidence that everyday factors clearly increase or lower gene-related risk. If someone has a harmful CHRND change, the chance of related symptoms is mostly tied to the inherited variant itself, although the severity can vary from one person to another.
Inheritance of CHRND variants
The inheritance of CHRND gene variants depends on the specific CHRND related condition. Well established CHRND related conditions can follow either an autosomal recessive pattern, where a child inherits one variant from each parent, or an autosomal dominant pattern, where one altered copy can be enough to cause disease. In families with a recessive condition, parents are often unaffected carriers. In families with a dominant condition, an affected parent can pass the variant to a child with a 50% chance in each pregnancy.
What does my CHRND result mean for my family?
For CHRND, what it means for family members depends on the exact result, because this gene is linked to conditions that can run in families in more than one way. In many families, parents are healthy carriers, so brothers, sisters, and future children may also be carriers or, less often, be affected. In some families, a CHRND change can be passed down in a dominant pattern, which means close relatives may also have the variant and may want to learn whether it applies to them.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for CHRND variants usually uses a blood or saliva sample to read the CHRND gene and look for changes linked to congenital myasthenic syndrome or related findings. Results may show a pathogenic variant, a benign variant, or a variant of uncertain significance, which means the change is not yet clearly understood.
When should I consider getting a genetic test?
Testing for CHRND may be worth discussing if a baby or child has unexplained muscle weakness, poor feeding, breathing problems, or droopy eyelids from early life, especially if similar problems run in the family. It can also help clarify some severe conditions linked to reduced movement before birth and stiff joints at birth.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it explains depends on the condition and on the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, also influence how the body functions. In some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is most helpful when considered with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body handles certain medicines, so the same treatment may work differently from one person to another. Some people process a drug more slowly or more quickly, while others are more or less sensitive to its effects. These common differences can influence how well a medicine works and the chance of side effects.
What is Pharmacogenetics?
Pharmacogenetics examines the way genetic differences shape responses to medications. By studying links between genes and specific drugs, it helps explain why the same treatment can affect people differently. For many medicines, genes influence both how the body handles a drug and how strong its effects may be. This information can support treatment decisions that are more informed and more tailored to the individual. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the CHRND gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medicine response, so if you have questions about a treatment, side effects, or new symptoms, talk with your doctor.
History
Initially understood only through visible traits, later recognized as tied to a specific gene, CHRND entered the medical literature through research on inherited muscle weakness present from birth. In the late 1980s, scientists identified and mapped the CHRND gene as one of the genes that make up the muscle acetylcholine receptor, a major step in clarifying these family patterns. From these first observations, research expanded steadily. During the 1990s and 2000s, pathogenic variants in the CHRND gene were linked to congenital myasthenic syndromes and to forms of fetal akinesia and multiple pterygium syndrome. These discoveries helped connect long-recognized clinical patterns with a specific inherited cause and improved genetic diagnosis for affected families.